Pricing

Vericel

0 followers

‌

Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Dominick Colangelo

President & CEO

Dominick Colangelo

Collapse

Joe Mara

CFO

Jonathan Hopper

Chief Medical Officer

Sean Flynn

SVP, General Counsel & Secretary

Mike Halpin

SVP, Quality & Regulatory Affairs

Patrick Fowler

SVP, Corporate Development & Strategy

Roland DeAngelis

SVP, Commercial Operations

Doug Kennedy

SVP, Operations

Heidi Hassen

SVP, Human Resources

Shannon Kelly

VP, Burn Care National Sales

VP, MACI Sales

VP, Manufacturing

VP, Quality

VP, Marketing & Commercial Strategy

Demet Durak

Senior Executive Assistant To The CEO

Teams

+28

Sales and Marketing

31 members

+12

Clinical and Medical Affairs

15 members

Operations and Development Team

12 members

Quality and Regulatory

9 members

Directors Team

9 members

Finance and Accounting

8 members

Offices

Similar companies

Kura Oncology

20 followers

REVOLUTION Medicines

5 followers

Dyne Therapeutics

3 followers

Precigen

3 followers

Arcturus Therapeutics

2 followers

Biocytogen

2 followers

Gamida Cell

2 followers

Fortis Life Sciences

1 follower

Entrada Therapeutics

1 follower

Century Therapeutics

1 follower

Cabaletta Bio

1 follower

Explore companies